Phase II trial of latrepidine in patients with mild-to-moderate Alzheimer's disease.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Nov 2010
At a glance
- Drugs Latrepirdine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Medivation
- 05 Nov 2010 New trial record.